OCTINOXATE AND TITANIUM DIOXIDE

N/A

Manufactured by Noxell

22 FDA adverse event reports analyzed

Last updated: 2026-04-15

About OCTINOXATE AND TITANIUM DIOXIDE

OCTINOXATE AND TITANIUM DIOXIDE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Noxell. The most commonly reported adverse reactions for OCTINOXATE AND TITANIUM DIOXIDE include ASPHYXIA, BLISTER, DYSPNOEA, EYE DISORDER, EYE PAIN. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for OCTINOXATE AND TITANIUM DIOXIDE.

Top Adverse Reactions

ASPHYXIA1 reports
BLISTER1 reports
DYSPNOEA1 reports
EYE DISORDER1 reports
EYE PAIN1 reports
EYE SWELLING1 reports
GINGIVAL BLISTER1 reports
GINGIVAL PAIN1 reports
HYPERSENSITIVITY1 reports
HYPOXIA1 reports
LIP BLISTER1 reports
LIP SWELLING1 reports
OBSTRUCTIVE AIRWAYS DISORDER1 reports
OEDEMA MOUTH1 reports
ORAL MUCOSAL BLISTERING1 reports
PHARYNGEAL OEDEMA1 reports
RASH1 reports
RASH ERYTHEMATOUS1 reports
SECRETION DISCHARGE1 reports
SKIN SWELLING1 reports
SWELLING FACE1 reports
UPPER AIRWAY OBSTRUCTION1 reports

Report Outcomes

Out of 1 classified reports for OCTINOXATE AND TITANIUM DIOXIDE:

Serious 100.0%Non-Serious 0.0%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female1 (100.0%)

Reports by Age

Age 391 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with OCTINOXATE AND TITANIUM DIOXIDE?

This profile reflects 22 FDA FAERS reports that mention OCTINOXATE AND TITANIUM DIOXIDE. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for OCTINOXATE AND TITANIUM DIOXIDE?

Frequently reported terms in FAERS include ASPHYXIA, BLISTER, DYSPNOEA, EYE DISORDER, EYE PAIN, EYE SWELLING. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures OCTINOXATE AND TITANIUM DIOXIDE?

Labeling and FAERS entries often list Noxell in connection with OCTINOXATE AND TITANIUM DIOXIDE. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.